Rebalance’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
1,352
+1
+0.1% +$233 0.02% 89
2026
Q1
$330K Sell
1,351
-69
-5% -$16.1K 0.02% 87
2025
Q4
$294K Buy
1,420
+72
+5% +$14.2K 0.02% 90
2025
Q3
$250K Sell
1,348
-212
-14% -$36.3K 0.02% 92
2025
Q2
$238K Buy
1,560
+2
+0.1% +$307 0.02% 90
2025
Q1
$258K Buy
+1,558
New +$244K 0.02% 87
2024
Q4
Sell
-1,344
Closed -$218K 100
2024
Q3
$218K Buy
+1,344
New +$214K 0.02% 92
2023
Q1
Sell
-81
Closed -$14.3K 100
2022
Q4
$14.3K Buy
+81
New +$14K ﹤0.01% 122

Other funds holding JNJ

Rebalance's JNJ Position: Q2 2026 in Review

Rebalance increased its Johnson & Johnson (JNJ) stake by 0.07% in Q2 2026, buying an estimated $233 and bringing the position to 1,352 shares worth $343K. The position accounts for 0.02% of the portfolio, ranked #89.

Rebalance first reported a position in JNJ in Q4 2022 and has held it in 8 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Rebalance held 1,352 shares of Johnson & Johnson worth $343K as of Q2 2026.
  • Rebalance bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.02% of Rebalance's portfolio in Q2 2026, its #89 holding.
  • Rebalance first reported a position in Johnson & Johnson in Q4 2022 and has held it in 8 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.